Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2001
01/03/2001EP1064303A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
01/03/2001EP1064302A1 Secreted proteins and polynucleotides encoding them
01/03/2001EP1064301A1 Bacterial yael family members as targets for antimicrobial drug design
01/03/2001EP1064297A1 95 human secreted proteins
01/03/2001EP1064295A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS
01/03/2001EP1064027A1 Apo-2 ligand-anti-her-2 antibody synergism
01/03/2001EP1064025A2 Combined vaccine compositions
01/03/2001EP1064024A1 Vaccines against circovirus infections
01/03/2001EP1064022A1 Hla-binding peptides and their uses
01/03/2001EP1064020A1 Methods for diagnosing and treating autoimmune disease
01/03/2001EP1064018A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
01/03/2001EP1064015A2 Receptor derived peptides as modulators of receptor activity
01/03/2001EP1064014A2 Medicament for preventing or treating papilloma virus-specific tumors
01/03/2001EP1064013A1 $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES
01/03/2001EP1064012A1 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding
01/03/2001EP1064011A1 Metastatin and hyaluronate binding proteins and methods of use
01/03/2001EP1064010A1 Peptide compositions and formulations and use of same
01/03/2001EP1064007A1 nrdG
01/03/2001EP1064006A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
01/03/2001EP1063997A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
01/03/2001EP1063979A2 Plant cell cyclin genes
01/03/2001EP1063887A1 P53-dependent secretion of growth inhibitory factors
01/03/2001EP1063880A1 Plant promoter sequences and methods of use thereof
01/03/2001EP1017716A4 Car receptors and related molecules and methods
01/03/2001EP0828759B1 Process of high purity albumin production
01/03/2001EP0816506B1 System for the expression of heterologous antigens as fusion proteins
01/03/2001EP0727046B1 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
01/03/2001CN1278921A dsRNA/dsRNA-Binding protein methods and compositions
01/03/2001CN1278866A MPL ligand analogs
01/03/2001CN1278865A Tumor-specific antigens, methods for their production and their use for immunization and diagnosis
01/03/2001CN1278864A Genetically modified tumor-targeted bacteria with reduced virulence
01/03/2001CN1278829A Apeptide with an affinity for clotting factor VIII
01/03/2001CN1060216C Improved methods for the preparation of endotoxinbinding proteins
01/03/2001CN1060212C Dictyestelium dipeptidlaminopeptidase, its separation method and use thereof
01/03/2001CN1060178C Derivatives of structurally modified vip and pharmacetical compositions containing them for treating servual impotense of male
01/02/2001US6169232 Nucleotide sequences of genes encoding sink protein and uses thereof for improving the nutritional quality of feeds
01/02/2001US6169175 Dna sequence encoding a variant m2 polypeptide of influenza a having a deletion of a domain, thus causing a reduction in hydrophobicity and an increase solubility in aqueous buffers
01/02/2001US6169174 Dna coding for a protein of defined amino acid sequence which controls fiber formation; for improvements in textile, paper and food industries
01/02/2001US6169173 Cloning and functional expression of cholecystokinin/gastrin receptor-encoding DNA
01/02/2001US6169172 Chimeric protein of a protein of interest which is extended at amino-terminal with second defined amino acid sequence; for recombinant production in eukaryotic cells
01/02/2001US6169171 Dna sequence encoding a fusion protein including c-terminal portion of circumsporozoite protein, four or more tandem repeats of that protein immunodominant region, and surface antigen from hepatitis b virus; vaccines against malaria
01/02/2001US6169169 PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis
01/02/2001US6169167 Antibodies to ligands for HEK4 receptors
01/02/2001US6169166 Amino acid sequence of multidrug resistance protein; for developing agonists and antagonists; for transgenic or knockout animals
01/02/2001US6169109 Mixing one of a novel class of psoralen photosensitizers with said solution and irradiating the mixture
01/02/2001US6169074 Peptide inhibitors of neurotransmitter secretion by neuronal cells
01/02/2001US6169073 An oligopeptide or polypeptide for activating dna binding of wild-type p53 and select tumor-derived p53 mutants; use in therapy of cancer and other disorders characterized by excessive proliferation of certain cells and tissues
01/02/2001US6169072 Cyclic adhesion inhibitors
01/02/2001US6169071 Compounds and methods for modulating cell adhesion
01/02/2001US6169070 Mer receptor activation by gas6
01/02/2001US6169068 Treating lung disease or disorder by inhalating a protein
01/02/2001US6168946 gp75 as a tumor vaccine for melanoma
01/02/2001US6168943 Methods for making modified recombinant vesiculoviruses
01/02/2001US6168942 Attenuated forms of bovine viral diarrhea virus
01/02/2001US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport
01/02/2001US6168932 Generating diptheria toxicity protein; transforming insect cell with subsequent transcription, translation and isolation of diptheria toxicity protein
01/02/2001US6168931 Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
01/02/2001US6168929 Method of identifying agents that disrupt the interaction of SV40 T antigen with Dnak homologues
01/02/2001US6168928 Modification of pertussis toxin
01/02/2001US6168927 Expression of G protein coupled receptors in yeast
01/02/2001US6168926 Screening for modulators of preferential enzyme activity; incubating cells with modulators and detecting expression of reporter molecules, amplification of expression indicates an inhibitor, decreased expression indicates an activator
01/02/2001US6168920 Extracellular adhesive proteins
01/02/2001US6168804 Slow release antigen delivery systems; oligopeptide; monophosphoryl lipid a
01/02/2001US6168793 Heat shock protein 70 preparations in vaccination against cancer and infectious disease
01/02/2001US6168791 Antibodies that bind immunomodulators
01/02/2001US6168789 Covalently modified in its catalytic center by a phe-phe-arg-chloromethylketone
01/02/2001US6168786 Chimeric protein containing a protein of parainfluenza virus (piv-3) and a protein of respiratory syncytial virus (rsv); capable of protecting infants and similar susceptible individuals against diseases caused by both piv and rsv
01/02/2001US6168785 Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents
01/02/2001US6168784 Block the inflammatory effects of rantes, and are useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, rheumatoid arthritis and hiv infections
01/02/2001US6168783 Antagonists of interleukin-15
01/02/2001US6168778 Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes
01/02/2001CA2310896A1 Hcv polymerase suitable for crystal structure analysis and method for using the enzyme
01/02/2001CA2187274C Treatment of partial growth hormone insensitivity syndrome
01/02/2001CA2171832C Alpha1-acid glycoprotein purification process and product
01/02/2001CA2113203C Human calcium channel compositions and methods
01/02/2001CA2086918C Biologically active compounds from blue-green algae
01/02/2001CA2064039C Treatment to reduce edema for brain and musculature injuries
01/02/2001CA2025070C Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof
01/02/2001CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof
01/02/2001CA1341160C Bovine granulocyte-macrophage colony stimulating factor
12/2000
12/29/2000CA2300467A1 Cancer vaccines
12/28/2000WO2000079284A1 Cartilage resorption assays
12/28/2000WO2000079267A2 Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer
12/28/2000WO2000079002A1 Means for identifying the locus of a major resistance gene with respect to the virus of the rice yellow mottle virus and uses thereof
12/28/2000WO2000079001A1 Means for identifying a novel class of genes resistant to the rice yellow mottle virus and the locus of a major gene of resistance to the virus, and their applications
12/28/2000WO2000078995A1 Detection of salmonella enteritidis
12/28/2000WO2000078986A1 Regulation system of expression using nuclear ppar receptors
12/28/2000WO2000078983A2 Sunflower anti-pathogenic proteins and genes and their uses
12/28/2000WO2000078978A1 Pichia methanolica glyceraldehyde 3-phosphate dehydrogenase 1 promoter and terminator
12/28/2000WO2000078972A2 Regulation with binding cassette transporter protein abc1
12/28/2000WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides
12/28/2000WO2000078970A1 Nucleic and proteinic acids corresponding to human gene abc1
12/28/2000WO2000078969A1 Hiv tat peptides and multiple peptide conjugate system
12/28/2000WO2000078968A2 Nucleotide sequences of moraxella catarrhalis genome
12/28/2000WO2000078967A1 Avirulent xanthomonas-campestris strains producing xanthan
12/28/2000WO2000078966A1 Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
12/28/2000WO2000078965A2 Plant auxin proteins
12/28/2000WO2000078964A1 Glycoprotein hormone family member
12/28/2000WO2000078963A1 Serin proteinase inhibitors
12/28/2000WO2000078962A1 Lsr, a cdna of the ig superfamily expressed in human leukocytes